Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

IP-751 effective in animal model of interstitial cystitis

March 11, 2005

Tsumura discontinues development of TJN-598

March 10, 2005

Lipid extract from palm fruit effective in testosterone-induced prostatic hypertrophy in rats

March 7, 2005

Cizolirtine enters phase II for stress urinary incontinence

Feb. 25, 2005

Sosei inlicenses urology drug from Otsuka

Feb. 25, 2005

Novel 5-HT/noradrenaline reuptake inhibitors claimed by Pfizer

Feb. 24, 2005

Enablex launched in U.S.

Feb. 24, 2005

Amitriptyline studied for painful bladder syndrome and interstitial cystitis

Feb. 22, 2005

Enrollment completed in phase II study of avanafil

Feb. 22, 2005

Solifenacin enhances quality of life in overactive bladder patients

Feb. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...